Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Merck
Harvard Business School
Chinese Patent Office
Express Scripts
Cerilliant
Novartis
Johnson and Johnson
Julphar
UBS

Generated: February 20, 2018

DrugPatentWatch Database Preview

Details for Patent: 7,566,445

« Back to Dashboard

Summary for Patent: 7,566,445
Title:Medicinal aerosols and methods of delivery thereof
Abstract:This invention provides a medicinal aerosol formulation comprising a particulate medicament, a fluorocarbon propellant and 6% to 25% w/w of the total formulation of a polar co-solvent, wherein the aerosol formulation is free of surfactant. This invention also provides a medicinal aerosol formulation, including one or more particulate medicaments, one or more fluorocarbon or hydrocarbon or aliphatic gas propellants and 6% to 25% w/w of a polar co-solvent. In addition, this invention provides a canister suitable for delivering a pharmaceutical aerosol formulation, which comprises a container capable of withstanding the vapour pressure of the propellant used, which container is closed with a metering valve and contains a pharmaceutical aerosol formulation which comprises particulate medicament, a propellant, and 6% to 25% of a polar co-solvent, which is substantially free of surfactant, wherein the propellant comprises a fluorocarbon.
Inventor(s): Millar; Fiona Catherine (Waterford, IE)
Assignee: Norton Healthcare Limited (GB)
Application Number:08/999,752
Patent Claim Types:
see list of patent claims
Formulation; Delivery;

Drugs Protected by US Patent 7,566,445

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 7,566,445

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom9616237.5Aug 01, 1996

International Patents Family Members for US Patent 7,566,445

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Norway 325491 ➤ Try a Free Trial
Norway 990454 ➤ Try a Free Trial
Japan 2011173910 ➤ Try a Free Trial
Japan 4794701 ➤ Try a Free Trial
Japan 2000515536 ➤ Try a Free Trial
United Kingdom 9616237 ➤ Try a Free Trial
Spain 2175413 ➤ Try a Free Trial
European Patent Office 0918507 ➤ Try a Free Trial
Denmark 0918507 ➤ Try a Free Trial
Germany 69711637 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
US Department of Justice
Deloitte
Teva
Chinese Patent Office
McKinsey
Cerilliant
Julphar
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot